Hemogram features of patients with various severity of multidrug-resistant tuberculosis.
Abstract
This article describes the study of the hemogram of patients with various severity of multidrug-resistant tuberculosis, also it shows the changes of the clusters of white and red blood cells at the onset. We analyzed the medical histories of twenty patients, who were treated in the department of LTO-2 of the National scientific center of phthisiopulmonology of the Republic of Kazakhstan. The research shows that regardless of the various severity the difference in the hemogram where insignificant, however, there were changes in the acute-phase proteins.
About the Authors
M. B. Tulegenova
Kazakh-Russian medical University
Kazakhstan
Kazakhstan
G. A. Suyunchaliyeva
Kazakh-Russian medical University
Kazakhstan
Kazakhstan
A. A. Umraliyeva
Kazakh-Russian medical University
Kazakhstan
Kazakhstan
A. Salamatov
Kazakh-Russian medical University
Kazakhstan
Kazakhstan
D. E. Sauhimov
Kazakh-Russian medical University
Kazakhstan
Kazakhstan
M. T. Zhaparov
Kazakh-Russian medical University
Kazakhstan
Kazakhstan
A. A. Akimzhanov
Kazakh-Russian medical University
Kazakhstan
Kazakhstan
References
1. K. Rohini M. Surekha Bhat, P. S. Srikumar, and A. Mahesh Kumar. Assessment of Hematological Parameters in Pulmonary Tuberculosis Patients.Indian J Clin Biochem. 2016 Jul; 31(3): 332–335. [PubMed]
2. Global Tuberculosis Report 2018
3. Peter A Minchella, Simon Donkor, Olumuyiwa Owolabi, Jayne S Sutherland, Joann M McDermid.Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions. 2015 March 1, 60 (5): 764-72. [PubMed]
4. J Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, Jeannette Brand, Julia Ershova, Thelma Tupasi, Janice Campos Caoili, Tracy Dalton, Carmen Contreras. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance. An Official Publication of the Infectious Diseases Society of America 2016 February 15, 62 (4): 418-430.
5. Мякишева Т.В. Диссертация: Особенности течения и эффективность лечения туберкулеза легких с лекарственной устойчивостью возбудителя у лиц молодого возраста. Москва 2013 год.
6. К.С. Игембаева, Р.С. Игембаева, А.Ж. Токпаева, Н.К. Селиханова, А.Б. Оразгалиева, А.С. Саламатов, А.Н. Строкань. Лекарственно-устойчивый туберкулез среди впервые выявленных больных. Журнал Наука и здравоохранение. 2013 г.
7. Dietrich J, Doherty TM. Interaction of mycobacterium tuberculosis with the host: consequences for vaccine development. APMIS. 2009;117:440–457. doi: 10.1111/j.1600-0463.2009.02458.x. [PubMed] [CrossRef] [Google Scholar]
8. Peresi E, Silva SM, Calvi SA, Marcondes-Machado J. Cytokines and acute phase serum proteins as markers of inflammatory regression during the treatment of pulmonary tuberculosis. J Bras Pneumol. 2008;34(11):942–949. doi: 10.1590/S1806-37132008001100009. [PubMed] [CrossRef] [Google Scholar]
9. Lee SW, Kang YA, Yoon YS, Um SW, Lee SM, Yoo CG, et al. The prevalence and evolution of anemia associated with tuberculosis. J Korean Med Sci. 2006;21(6):1028–1032. doi: 10.3346/jkms.2006.21.6.1028. [PMC free article] [PubMed] [CrossRef] [Google Scholar].
10. Van Lettow M, Kumwenda JJ, Harries AD, Whalen CC, Taha TE, Kumwenda N, et al. Malnutrition and the severity of lung disease in adults with pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis. 2004;8(2):211–217. [PubMed] [Google Scholar]
11. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–1023. doi: 10.1056/NEJMra041809. [PubMed] [CrossRef] [Google Scholar]
Review
For citations:
Tulegenova M.B., Suyunchaliyeva G.A., Umraliyeva A.A., Salamatov A., Sauhimov D.E., Zhaparov M.T., Akimzhanov A.A. Hemogram features of patients with various severity of multidrug-resistant tuberculosis. Actual Problems of Theoretical and Clinical Medicine. 2019;(4):64-66. (In Russ.)
Views:
172
